Vaccination against human papillomavirus.
Reads0
Chats0
TLDR
The human papillomavirus infection is a public health concern because it has been associated with genital tract malignant diseases among men and women.Abstract:
Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.read more
Citations
More filters
Journal ArticleDOI
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
TL;DR: In this article , the authors introduced the working mechanism of cancer vaccines and summarized four platforms for cancer vaccine development and highlighted the clinical research progress of the cancer vaccines, especially focusing on their clinical application and therapeutic efficacy.
Journal ArticleDOI
Involvement of Human Papillomaviruses in Cervical Cancer.
TL;DR: It is proposed that oxidative stress, mRNA, and the mechanisms of HPV infection will be critical points for HPV cancer research over the next decade.
Journal ArticleDOI
Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.
Maryam Dadar,Sandip Chakraborty,Kuldeep Dhama,Minakshi Prasad,Rekha Khandia,Sameer Hassan,Ashok Munjal,Ruchi Tiwari,Kumaragurubaran Karthik,Deepak Kumar,Hafiz M.N. Iqbal,Wanpen Chaicumpa +11 more
TL;DR: The present review presents a current global scenario and futuristic prospects of the advanced prophylactic and therapeutic approaches against HPV along with recent patents coverage of the progress and advances in drugs, vaccines and therapeutic regimens to effectively combat HPV infections and its cancerous conditions.
Journal ArticleDOI
Recombinant protein vaccines, a proven approach against coronavirus pandemics.
TL;DR: The current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections is summarized.
Journal ArticleDOI
Infecção pelo papilomavírus humano (hpv) na mucosa ocular: uma revisão de literatura
Yanna Emilly Oliveira Da Silva,Iandra Mairan Santos Silva,Alisson De Aquino Firmino,Marcella Boaventura e Carvalho +3 more
TL;DR: A metodologia do estudo consiste em uma revisão bibliográfica integrativa, com caráter descritivo e qualitativo, e recorte temporal de 2000 a 2022, tendo como objetivo principal identificar o comportamento do HPV na mucosa ocular and associá-lo às neoplasias nessa região, além de ressaltar a importância da vacinação as mentioned in this paper .
References
More filters
Book
Principles and Practice of Infectious Diseases
TL;DR: This updated and expanded edition now offers 297 chapters that cover the basic principles of diagnosis and management, major clinical syndromes, all important pathogenic microbes and the diseases they cause, plus a number of specialised topics useful to the practitioner.
Journal ArticleDOI
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Jorma Paavonen,Paulo Naud,Jorge Salmerón,Cosette M. Wheeler,Song-Nan Chow,D Apter,Henry C Kitchener,Xavier Castellsagué,Julio Cesar Teixeira,S R Skinner,James Hedrick,Unnop Jaisamrarn,Genara Limson,Suzanne M. Garland,Anne Szarewski,Barbara Romanowski,Fred Y. Aoki,Tino F. Schwarz,Willy Poppe,Franz X. Bosch,David Jenkins,Karin Hardt,Toufik Zahaf,Dominique Descamps,Frank Struyf,Matti Lehtinen,Gary Dubin +26 more
TL;DR: The HPV- 16/18 AS04-adjuvanted vaccine showed high efficacy against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types and substantial overall effect in cohorts that are relevant to universal mass vaccination and catch-up programmes.
Journal Article
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E. Markowitz,Eileen F. Dunne,Mona Saraiya,Herschel W. Lawson,Harrell W. Chesson,Elizabeth R. Unger +5 more
TL;DR: The first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine was made by the U.S. Food and Drug Administration on June 8, 2006 as mentioned in this paper.
Journal ArticleDOI
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Anna R. Giuliano,Joel M. Palefsky,Stephen E. Goldstone,Edson D. Moreira,Mary E. Penny,Carlos Aranda,Eftyhia Vardas,Harald Moi,Heiko Jessen,Richard J. Hillman,Yen Hwa Chang,Daron G. Ferris,Danielle Rouleau,Janine T. Bryan,J. Brooke Marshall,Scott Vuocolo,Eliav Barr,David Radley,Richard M. Haupt,Dalya Guris +19 more
TL;DR: Quadrivalent HPV vaccine prevents infection with HPV-6, 11, 16, and 18 and the development of related external genital lesions in males 16 to 26 years of age.